Table 1.
Baseline Characteristics of Participants in Research and Control Groups
| Characteristics | Research (Zoledronic Acid) | Control | P value |
|---|---|---|---|
| Sample size (n) | 113 | 118 | |
| Age, years, mean (SD) | 67.1 (6.5) | 65.1 (7.9) | 0.28 |
| Women, % (n) | 91.2% (103) | 88.1% (104) | 0.15 |
| Height, cm, mean (SD) | 154.3 (7.8) | 155.7 (8.5) | 0.09 |
| Weight, kg, mean (SD) | 48.3 (8.1) | 49.5 (9.9) | 0.12 |
| BMI, kg/m2, mean (SD) | 20.3 (2.9) | 20.4 (3.1) | 0.33 |
| ASM, g, mean (SD) | 13,310 (1899) | 13,899 (1955) | 0.19 |
| ASMI, kg/m2, mean (SD) | 5.59 (0.72) | 5.66 (0.74) | 0.26 |
| BMD, g/cm2, mean (SD) | |||
| Lumbar spine | 0.717 (0.152) | 0.721 (0.154) | 0.15 |
| Femoral neck | 0.665 (0.091) | 0.682 (0.117) | 0.19 |
Abbreviations: ASM, appendicular skeletal muscle mass; ASMI, appendicular skeletal muscle mass index; BMD, bone mineral density; BMI, body mass index; SD, standard deviation.